UBS Group’s Cartesian Growth Corporation Unit GLBLU Stock Holding History

UBS Group’s Portfolio GLBLU Stock Details GLBLU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-367	Closed	-$4.22K	–	11534
2022 Q4	$4.22K	Buy	367 +243	+196%	+$2.44K	﹤0.01%	9360
2022 Q3	$1K	Hold	124	–	–	﹤0.01%	10219
2022 Q2	$1K	Buy	124 +80	+182%	+$803	﹤0.01%	10147
2022 Q1	$0	Sell	44 -1	-2%	-$10	﹤0.01%	11351
2021 Q4	$0	Sell	45 -327	-88%	-$3.34K	﹤0.01%	11091
2021 Q3	$4K	Sell	372 -878	-70%	-$8.75K	﹤0.01%	8743
2021 Q2	$12K	Sell	1,250 -2,072	-62%	-$20.7K	﹤0.01%	7923
2021 Q1	$33K	Buy	+3,322	New	+$33.2K	﹤0.01%	6939

UBS Group's GLBLU Position: Q1 2023 in Review

UBS Group sold out of Cartesian Growth Corporation Unit (GLBLU) in Q1 2023, closing a stake of 367 shares — an estimated $4.22K sold.

UBS Group first reported a position in GLBLU in Q1 2021 and held it in 8 quarters. The position peaked at $33K in Q1 2021. 0 funds tracked by Wall St. Rank hold GLBLU as of Q1 2023.

UBS Group reported no remaining Cartesian Growth Corporation Unit position as of Q1 2023 after selling out during the quarter.
UBS Group sold 367 Cartesian Growth Corporation Unit shares in Q1 2023, an estimated $4.22K.
UBS Group first reported a position in Cartesian Growth Corporation Unit in Q1 2021 and held it in 8 quarters.
UBS Group's Cartesian Growth Corporation Unit position peaked at $33K in Q1 2021.
0 funds tracked by Wall St. Rank held Cartesian Growth Corporation Unit as of Q1 2023.

Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.